The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Irinotecan and temozolomide combined with dasatinib and rapamycin for patients with relapsed or refractory neuroblastoma: Results of the prospective randomized RIST trial.
 
Selim Corbacioglu
No Relationships to Disclose
 
Holger N. Lode
Honoraria - EUSA Pharma
Consulting or Advisory Role - EUSA Pharma
Research Funding - EUSA Pharma (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - EUSA Pharma
 
Marcus Jakob
No Relationships to Disclose
 
Meinolf Suttorp
No Relationships to Disclose
 
Gabriele Escherich
No Relationships to Disclose
 
Bernd Gruhn
No Relationships to Disclose
 
Susanne Ellinger
No Relationships to Disclose
 
Thorsten Simon
Consulting or Advisory Role - EUSA Pharma (Inst); Merck; Norgine
 
Peter Lang
Research Funding - EUSA Pharma
 
Marius Rohde
No Relationships to Disclose
 
Florian Zeman
No Relationships to Disclose
 
Klaus-Michael Debatin
No Relationships to Disclose
 
Andreas Beilken
No Relationships to Disclose
 
Peter Heiss
No Relationships to Disclose
 
Dirk Hellwig
No Relationships to Disclose
 
Markus Riemenschneider
No Relationships to Disclose
 
Ruth Lydia Ladenstein
Consulting or Advisory Role - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma (Inst)
Research Funding - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Expert Testimony - Apeiron Biologics; EUSA Pharma
 
Konrad Bochennek
No Relationships to Disclose
 
Angelika Eggert
Consulting or Advisory Role - EUSA Pharma
 
Juergen Foell
No Relationships to Disclose